Gal-9 directly promotes pro-inflammatory antibacterial immune responses and increased PAD-4 activity, which we suggest may represent a possible mechanism for breakdown of tolerance and development of RA in susceptible individuals. Here, PADI4 is linked to rheumatoid arthritis.